Patents by Inventor Sanne Moeller Knudsen

Sanne Moeller Knudsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating steroid-induced obesity using GLP-1 agonists
    Patent number: 8853157
    Abstract: The present invention describes administering a GLP-1 agonist to treat obesity caused by the administration of an obesity-inducing drug.
    Type: Grant
    Filed: February 26, 2013
    Date of Patent: October 7, 2014
    Assignee: Novo Nordisk A/S
    Inventors: Sanne Moeller Knudsen, Karin Rimvall
  • Counteracting drug-induced obesity using GLP-1 agonists
    Patent number: 8410047
    Abstract: The present invention describes administering a GLP-1 agonist to treat obesity caused by the administration of an obesity-inducing drug.
    Type: Grant
    Filed: May 31, 2005
    Date of Patent: April 2, 2013
    Assignee: Novo Nordisk A/S
    Inventors: Camilla Bock, Sanne Møller Knudsen, Karin Rimvall
  • Long-Acting Y2 and/or Y4 Receptor Agonists
    Publication number: 20110275559
    Abstract: The present invention relates to a PYY or PP peptide derivative or analogue thereof derivatised with one or more serum albumin binding side chains comprising a dis-tal tetrazole or carboxylic acid group. Moreover, the invention relates to compositions hereof and methods of treatment of conditions responsive to Y receptor modulation.
    Type: Application
    Filed: May 18, 2009
    Publication date: November 10, 2011
    Applicant: Novo Nordisk A/S
    Inventors: Søren Østergaard, Sanne Møller Knudsen, Jane Spetzler, Rasmus Jørgensen, Jacob Kofoed